Market Tracker

09/22 3:40am ET

Shire PLC (NASDAQ:SHPG)

155.36
Delayed Data
As of Sep 21
 +1.96 / +1.28%
Today’s Change
139.36
Today|||52-Week Range
206.94
-8.82%
Year-to-Date
Is Shire plc (SHPG) a Suitable Value Stock?
Sep 21 / Zacks.com - Paid Partner Content
Top Research Reports for Disney, Kraft Heinz & CVS Health
Sep 12 / Zacks.com - Paid Partner Content
Supernus Drops SPN-810's Lower Dose Test in Phase III Trials
Sep 19 / Zacks.com - Paid Partner Content
Alnylam Shares Plunge on Patient Death, Dosing Suspended
Sep 08 / Zacks.com - Paid Partner Content
Neos Therapeutics ADHD Drug Adzenys Receives Approval in US
Sep 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close153.40
Today’s open152.97
Day’s range152.94 - 156.02
Volume883,114
Average volume (3 months)1,324,463
Market cap$46.4B
Dividend yield0.59%
Data as of 3:59pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)-80.61%
Earnings growth (this year)+14.68%
Earnings growth (next 5 years)+10.78%
Revenue growth (last year)+76.71%
P/E ratio79.7
Price/Sales3.89
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-0.66-0.43%
REGNRegeneron Pharmaceut...-4.72-1.08%
BAXBaxter International...-0.90-1.40%
ALXNAlexion Pharmaceutic...0.000.00%
Data as of 3:59pm ET, 09/21/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)$3.65
Annual revenue (last year)$11.3B
Annual profit (last year)$325.1M
Net profit margin5.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts